<![CDATA[Daraxonrasib Shows SOC Potential in Metastatic PDAC]]>

Summary: The RAS Revolution is Here

Pancreatic cancer met its match.

Daraxonrasib: 13.2 months survival.

Chemo: 6.6 months.

Less pain. Better life.

RIP standard chemo.

---